The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Gold Nanoparticles for Drug Delivery and Cancer Therapy
Open accessAbstract
Nanomaterials are popularly used in drug delivery, disease diagnosis and therapy. Among a number of functionalized nanomaterials such as carbon nanotubes, peptide nanostructures, liposomes and polymers, gold nanoparticles (Au NPs) make excellent drug and anticancer agent carriers in biomedical and cancer therapy application. Recent advances of synthetic technique improved the surface coating of Au NPs with accurate control of particle size, shape and surface chemistry. These make the gold nanomaterials a much easier and safer cancer agent and drug to be applied to the patient’s tumor. Although many studies on Au NPs have been published, more results are in the pipeline due to the rapid development of nanotechnology. The purpose of this review is to assess how the novel nanomaterials fabricated by Au NPs can impact biomedical applications such as drug delivery and cancer therapy. Moreover, this review explores the viability, property and cytotoxicity of various Au NPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system
Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., & Whyman, R. (1994) · J. Chem. Soc., Chem. Commun. · doi:10.1039/c39940000801 · Cited by 6,707
Turkevich Method for Gold Nanoparticle Synthesis Revisited
Kimling, J., Maier, M., Okenve, B., Kotaidis, V., Ballot, H., & Plech, A. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp061667w · Cited by 2,281
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
El-Sayed, I. H., Huang, X., & El-Sayed, M. A. (2005) · Nano Letters · doi:10.1021/nl050074e · Cited by 1,919
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
Alkilany, A. M., & Murphy, C. J. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9911-8 · Cited by 1,485
Gold nanoparticles as novel agents for cancer therapy
Jain, S., Hirst, D. G., & O'Sullivan, J. M. (2012) · The British Journal of Radiology · doi:10.1259/bjr/59448833 · Cited by 1,059
A New Era for Cancer Treatment: Gold‐Nanoparticle‐Mediated Thermal Therapies
Kennedy, L. C., Bickford, L. R., Lewinski, N. A., Coughlin, A. J., Hu, Y., Day, E. S., West, J. L., & Drezek, R. A. (2011) · Small · doi:10.1002/smll.201000134 · Cited by 885
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
Riley, R. S., & Day, E. S. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1449 · Cited by 801
Defining Rules for the Shape Evolution of Gold Nanoparticles
Langille, M. R., Personick, M. L., Zhang, J., & Mirkin, C. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305245g · Cited by 707
Cited by
A review on nanoparticles: characteristics, synthesis, applications, and challenges
Altammar, K. A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1155622 · Cited by 1,067
Abbasi, R., Shineh, G., Mobaraki, M., Doughty, S., & Tayebi, L. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05690-w · Cited by 623
Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Nanomaterials · doi:10.3390/nano10091700 · Cited by 402
Self-citationAlsaiari, N. S., Alzahrani, F. M., Amari, A., Osman, H., Harharah, H. N., Elboughdiri, N., & Tahoon, M. A. (2023) · Molecules · doi:10.3390/molecules28010463 · Cited by 357
Abuzeid, H. M., Julien, C. M., Zhu, L., & Hashem, A. M. (2023) · Crystals · doi:10.3390/cryst13111576 · Cited by 344
Metadata
- Authors
- Siddique, S., & Chow, J. C. L.
- Venue
- Applied Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-31
- Volume
- 10
- Issue
- 11
- Pages
- 3824
- ISSN
- 2076-3417 (ISSN-L)
- OpenAlex
- W3029127089
- Cited by
- 446
- References
- 82
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gold Nanoparticles for Drug Delivery and Cancer Therapy. https://app.cochat.ai/papers/10.3390/app10113824
- The paper
- Siddique, S., & Chow, J. C. L. (2020). Gold Nanoparticles for Drug Delivery and Cancer Therapy. Applied Sciences. https://doi.org/10.3390/app10113824
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.